Home Blog Blog

Blog

24 April 2017
Ed Owen, Head of Stakeholder Engagement at the Medicines Discovery Catapult tells us about the importance of the patient voice in drug discovery and how medical research charities can help bring the unique insight of patients into the discovery process making for quicker, more efficient and, ultimately, more effective therapies down the line.
19 April 2017
A new report published by the Charity Aid Foundation has found that medical research was the cause people were most likely to donate to in 2016. 
13 April 2017
There is an increasing demand for funders to assess their research impact more thoroughly. In March we held an Impact and Evaluation Masterclass to learn from medical research funders and research institutions about how best to collect and disseminate research impact. In this blog we have summarised the key points of the day.
6 April 2017
This is the third and final blog of AMRC’s series on Brexit and medical research. It looks at some of the regulations on medical research and health that will be affected by Brexit.
4 April 2017
Charlotte Pelekanou is a PhD student from the University of Manchester who has been working as a Research Intern for the past three months. Here she provides an overview of what she has been up to during her time at AMRC.
3 April 2017
In this second instalment of AMRC’s blog series highlighting key areas of focus for medical research charities as the UK prepares to leave the EU, we’re looking at one of the most thorny issues - changes to the movement of people.
30 March 2017
Last month children’s medical research charity Sparks announced that it will be joining Great Ormond Street Hospital Charity in a partnership. Elvira Morrison, Head of Sparks spoke to AMRC about the partnership and their first milestone - launching a joint National Call.
29 March 2017
This is the first instalment in a series of posts highlighting key issues facing medical research charities as the UK prepares to leave the EU. Now that Article 50 has been triggered and negotiations are set to commence, this blog looks at the potential impact of changes to EU funding.
29 March 2017
The Medicines Discovery Catapult was set up by Innovate UK as part of the UK's industrial strategy to support and enable commercial drug discovery in the UK. Today, Wednesday 29 March, it was announced that the Catapult has invested £1m into cutting-edge lab capacity. Chris Molloy, Chief Executive at the Catapult tells us how this investment will benefit the drug discovery community. 
23 March 2017
Adam Kamenetzky, Research Fellow, Policy Institute at King’s and Researcher-in-residence, NIHR Central Commissioning Facility tells us about the key takeaways from AMRC's Evaluation and Impact masterclass and explains how you can 'tame' the 'gorilla' of research impact.

Pages